Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Lundbeck discloses new PDE10A inhibitors

June 15, 2012

AstraZeneca and Dainippon Sumitomo Pharma present new TLR7 agonists

June 15, 2012

Instituto Biomar reports new agents from a marine microorganism

June 14, 2012

New antisense oligonucleotides designed at Japanese university

June 14, 2012

U.S. researchers disclose novel metalloenzyme inhibitors

June 14, 2012

Celgene patents novel inhibitors of mutant EGFR

June 14, 2012

New agents for pulmonary hypertension presented by Ironwood Pharmaceuticals

June 14, 2012

Novel anticancer TLR7 agonists disclosed

June 14, 2012

Jenrin Discovery designs novel compounds targeting the cannabinoid CB1 receptor

June 14, 2012

Novel agents for migraine prepared at Merck & Co.

June 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.